状细胞病:结合新疗法与CRISPR-Cas9的潜力和挑战 - 综述文章
1Pediatric Hematology and BMT Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
Annals of hematology
|October 22, 2023
概括
状细胞疾病 (SCD) 的治疗方法正在发展,基因疗法提供了潜在的治疗方法. 目前的组合疗法显示出希望,但与基于CRISPR的SCD基因编辑相比面临挑战.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 状细胞病 (SCD) 是一种普遍存在的遗传性血液疾病,影响全球数百万人.
- 最近的FDA批准为SCD管理提供了新的治疗选择.
- 的复杂病理生理学需要不同的治疗策略.
研究的目的:
- 审查目前用于SCD的组合疗法的疗效和安全性.
- 用CRISPR/Cas9.9来对比现有的治疗方法与新兴的状细胞基因疗法.
- 探索基因编辑造血干细胞移植作为SCD治愈方法的潜力.
主要方法:
- 关于SCD治疗的当前文献的综述.
- 对FDA批准的治疗方法及其局限性的分析.
- 探索CRISPR/Cas9技术用于血液形成干细胞中的基因编辑.
主要成果:
- 组合疗法提供了对SCD途径的补充向,但缺乏治愈潜力.
- 基于CRISPR/Cas9的基因疗法通过纠正潜在的遗传缺陷来提供潜在的治疗方法.
- 基因编辑干细胞移植可能会降低与常规移植相关的风险,例如移植对宿主疾病.
结论:
- 虽然新的组合疗法可以促进SCD治疗,但它们并不能治愈.
- 克里斯普尔/卡斯9基因疗法对SCD的潜在治疗具有重大前景.
- 长期监测对于确保基因编辑技术在临床环境中的安全性和有效性至关重要.
相关概念视频
What is Genetic Engineering?
Overview
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


